Group aims to elevate point-of-care marketing

Share this article:

Seven companies specializing in patient education and point-of-care media are banding together to form a trade group called the Point-of-Care Communications Council, or POC3 for short.

“The value provided by point-of-care channels is increasingly important to a wide variety of constituents in the market,” said Accent Health CEO Dan Stone, “to educate patients and improve healthcare outcomes. Since so much is changing in the market, and since we touch so many points in the system, we saw a benefit of coming together as an association to really help people better understand how to utilize the channels, which are being utilized more as access to the health system increases.”

Point-of-care marketing is a $500 million industry, the group estimates. Member companies include Catalina Health, HealthBridge, Health Media Network, Health Monitor Network, Patient Point and Time Inc.'s Targeted Media Health, along with Accent Health. Together they have a hundred years' experience in the space between them, says Stone, and touch virtually every patient in the system.

They'll host conferences, conduct research and issue white papers disseminating best practices – the bread and butter of trade associations. They'll also try and establish standards of measurement for point-of-care marketing.

“One of the things we're trying to achieve is to help set standardized measurements of investments in the point of care,” said PatientPoint CEO Tom McGuinness, “so that brands can compare in a very clear way investments they make in point-of-care versus investments in more traditional channels.”

The group holds its inaugural meeting June 12 in New York City. 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...